Last update 09 May 2026

dTAG-63

Overview

Basic Info

Drug Type
Proteolysis-targeting chimeras (PROTAC)
Synonyms
dTAG-63
Target
FKBP1A
Action
degraders
Mechanism
FKBP1A degraders(FK506-binding protein 1A degraders)
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Neoplasms
Originator Organization
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.Novartis Institutes for Biomedical Research, Inc.Novartis Institutes for Biomedical Research, Inc.Harvard Medical SchoolHarvard Medical School
Active Organization-
Inactive Organization
Novartis Institutes for Biomedical Research, Inc.Novartis Institutes for Biomedical Research, Inc.Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.Harvard Medical SchoolHarvard Medical School
License Organization-
Drug Highest PhasePendingPreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC69H92N6O17S
InChIKeyQTSHFYXEXAHVCR-DBYQZFFGSA-N
CAS Registry-

Related

100 Clinical Results associated with dTAG-63
Login to view more data
100 Translational Medicine associated with dTAG-63
Login to view more data
100 Patents (Medical) associated with dTAG-63
Login to view more data
1
Literatures (Medical) associated with dTAG-63
Nature communicationsQ1 · CROSS-FIELD
Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules
Q1 · CROSS-FIELD
100 Deals associated with dTAG-63
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPreclinical
United States
Harvard Medical SchoolHarvard Medical School
18 Sep 2020
NeoplasmsPreclinical
United States
Novartis Institutes for Biomedical Research, Inc.Novartis Institutes for Biomedical Research, Inc.
18 Sep 2020
NeoplasmsPreclinical
United States
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
18 Sep 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free